Clinical characteristics, tumor‐infiltrating lymphocytes, and prognosis in HER2‐low breast cancer: A comparison study with HER2‐zero and HER2‐positive disease

INTRODUCTION: HER2‐low breast cancer is a gradually recognized and unexplored group of diseases. We aimed to investigate the clinical and prognosis features and to identify the role of stromal tumor‐infiltrating lymphocytes (sTILs) in this population. METHODS: Consecutive primary breast cancer patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yujie, Tong, Yiwei, Fei, Xiaochun, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469737/
https://www.ncbi.nlm.nih.gov/pubmed/37366301
http://dx.doi.org/10.1002/cam4.6290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469737/
https://www.ncbi.nlm.nih.gov/pubmed/37366301
http://dx.doi.org/10.1002/cam4.6290

Ejemplares similares